Primed monocytes: Putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis

Clinical and Experimental Nephrology

Volumn 15, Issue 2, 2011, Pages 258-263

  Kim, Hye Won ^a   Woo, Young Seok ^a   Yang, Ha Na ^a   Choi, Hye Min ^a   Jo, Sang Kyung ^a   Cho, Won Yong ^a   Kim, Hyoung Kyu ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Hemodialysis; Inflammation; Monocytes; Toll like receptor 4

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CD14 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; IRON; LIPOPOLYSACCHARIDE; RECOMBINANT ERYTHROPOIETIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INFLAMMATION; INNATE IMMUNITY; KIDNEY FAILURE; MALE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; TREATMENT DURATION;

ANTIGENS, CD14; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; RENAL DIALYSIS; SERUM ALBUMIN; TOLL-LIKE RECEPTOR 4;

EID: 79959217992     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0379-8     Document Type: Article

References (21)

1. Collins AJ, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008;51(1 Suppl 1): S1-320.
2. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758-64.
3. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001;38(6):1408-13. (Pubitemid 34193135)
4. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47(1):139-48. (Pubitemid 41828276)
5. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina SM, et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis. 2003;42(1):44-52. (Pubitemid 36807653)
6. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55(5):1899-911. (Pubitemid 29197978)
7. Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O'Shea S, Owen WF Jr, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant. 2003;18(6):1167-73. (Pubitemid 36722520)
8. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499-511. (Pubitemid 38931765)
9. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406(6797):782-7.
10. Lonnemann G. When good water goes bad: how it happens, clinical consequences and possible solutions. Blood Purif. 2004;22(1):124-9. (Pubitemid 38142297)
11. Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant. 2001;16(9):1863-9. (Pubitemid 32821419)
12. Schindler R, Beck W, Deppisch R, Aussieker M, Wilde A, Gohl H, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol. 2004;15(12):3207-14. (Pubitemid 39578853)
13. Schindler R, Boenisch O, Fischer C, Frei U. Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol. 2000;53(6):452-9. (Pubitemid 30390075)
14. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K. Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int. 2006;70(2):358-62. (Pubitemid 44086586)
15. Girndt M, Sester U, Sester M, Kaul H, Kohler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant. 1999;14(12):2807-10.
16. Kuroki Y, Tsuchida K, Go I, Aoyama M, Naganuma T, Takemoto Y, et al. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients. Int J Mol Med. 2007;19(5):783-90.
17. Gollapudi P, Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol. 2010;31(3):247-54.
18. Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: role of oxidative stress. Blood Purif. 2002;20(5):481-4. (Pubitemid 35007567)
19. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol. 1994;14(3):253-60. (Pubitemid 24148566)
20. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469-76. (Pubitemid 30124077)
21. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648-58. (Pubitemid 29082891)